Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuko Abiko

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Diabetologia|December 24, 2015
Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in miceTsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, et al.
BMC Endocrine Disorders|October 17, 2019
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation testYasutaka Takeda, Yukihiro Fujita, Ryoichi Bessho, et al.
Diabetes|February 28, 2003
Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activationToru Abiko, Atsuko Abiko, Allen C Clermont, et al.
Endocrinology, Diabetes & Metabolism Case Reports|September 20, 2017
Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumorsYasutaka Takeda, Yukihiro Fujita, Kentaro Sakai, et al.
Frontiers in Medicine|October 10, 2022
Successful therapeutic strategy for a patient with obese end-stage kidney disease by simultaneous laparoscopic sleeve gastrectomy and implantation of a buried peritoneal dialysis catheter: A case reportTomohisa Yamashita, Tatsuya Sato, Kazuyuki Yamamoto, et al.
Molecular Metabolism|February 10, 2017
Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjectsTsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, et al.
Clinical and Experimental Nephrology|September 9, 2010
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitolTakashi Uzu, Hiroki Yokoyama, Hirofumi Itoh, et al.
Clinical Case Reports|May 3, 2021
A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancyTomoe Abe, Yasutaka Takeda, Takao Takiyama, et al.
Trials|December 4, 2025
Comparison of the effect on treatment satisfaction of switching from multiple insulin injection therapy to additional administration of imeglimin in subjects with type 2 diabetes (MEGMI-TS): study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison trialHiroya Kitsunai, Takashi Nanbu, Fumika Maruyama, et al.
Diabetes, Obesity & Metabolism|April 7, 2026
Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP StudyFumika Maruyama, Hiroya Kitsunai, Naoyuki Kitao, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Diabetologia|December 24, 2015
Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in miceTsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, et al.
BMC Endocrine Disorders|October 17, 2019
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation testYasutaka Takeda, Yukihiro Fujita, Ryoichi Bessho, et al.
Diabetes|February 28, 2003
Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activationToru Abiko, Atsuko Abiko, Allen C Clermont, et al.
Endocrinology, Diabetes & Metabolism Case Reports|September 20, 2017
Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumorsYasutaka Takeda, Yukihiro Fujita, Kentaro Sakai, et al.
Frontiers in Medicine|October 10, 2022
Successful therapeutic strategy for a patient with obese end-stage kidney disease by simultaneous laparoscopic sleeve gastrectomy and implantation of a buried peritoneal dialysis catheter: A case reportTomohisa Yamashita, Tatsuya Sato, Kazuyuki Yamamoto, et al.
Molecular Metabolism|February 10, 2017
Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjectsTsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, et al.
Clinical and Experimental Nephrology|September 9, 2010
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitolTakashi Uzu, Hiroki Yokoyama, Hirofumi Itoh, et al.
Clinical Case Reports|May 3, 2021
A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancyTomoe Abe, Yasutaka Takeda, Takao Takiyama, et al.
Trials|December 4, 2025
Comparison of the effect on treatment satisfaction of switching from multiple insulin injection therapy to additional administration of imeglimin in subjects with type 2 diabetes (MEGMI-TS): study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison trialHiroya Kitsunai, Takashi Nanbu, Fumika Maruyama, et al.
Diabetes, Obesity & Metabolism|April 7, 2026
Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP StudyFumika Maruyama, Hiroya Kitsunai, Naoyuki Kitao, et al.
Pageof 3